Bio-Techne, Fresenius Kabi, and Wilson Wolf have formed a new joint venture company to provide dedicated support to researchers and biopharmaceutical companies in the field of cell and gene therapy. The joint venture will focus on providing scalable manufacturing technologies and processes needed to develop and commercialize new cell and gene therapies. Each of the […]

Under an instrument evaluation agreement, researchers at the University of Pennsylvania will explore utilization of “MARS” platform of Applied Cells to assist in protocol development for areas of advanced cancer diagnosis and cancer treatment. Santa Clara, California – University of Pennsylvania (Penn) and Applied Cells, Inc., a Santa Clara, California based biotechnology company, announced today […]

SAN CARLOS, Calif., Jan. 16, 2020 — CellFE, Inc., an innovative startup developing a microfluidics based device to deliver gene-editing molecules, today announced it has raised $3.6 million in an initial Series Seed. The oversubscribed round is co-led by Cota Capital and Dynamk Capital, and joined by Embark Ventures. The round is expected to close with additional investors […]

Munich, Germany – Perform high-resolution, cost-effective cell culture experiments with ibidi’s latest innovative labware technology, the µ-Slide 18 Well family. With its thin ibidi Polymer Coverslip Bottom, the µ-Slide 18 Well allows for excellent cell adhesion onto the tissue culture-treated surface. In addition, it has the highest optical quality and is ideally suited for a variety of […]

SAN JOSE, Calif. & JERUSALEM Accellix, Inc. is pleased to announce the appointment of Nir Nimrodi as Chairman and Chief Executive Officer effective immediately. Mr. Nimrodi has served as the Executive Chairman of Accellix since June 2019. Mr. Nimrodi commented, “I joined Accellix as Executive Chairman in June of 2019, and after seven months of […]

Ann Arbor, Mich., and Beijing, China — Celsee, Inc., a leading provider of single-cell isolation technology, and Kindstar Global, the largest medical esoteric testing service group in China, today announced a purchase agreement to provide scientists at the Kindstar Laboratory System in China with Celsee’s Genesis System for monitoring circulating tumor cells (CTCs) in lung, […]

Pictured Thiolated Hyaluronic Acid Kits for 3D Hydrogels. Advanced BioMatrix acquires HyStem® technology for R&D market Technology highly synergistic with existing Advanced BioMatrix products Advanced BioMatrix to fully manufacture and distribute the HyStem® kits California, USA – Advanced BioMatrix has acquired the HyStem® line of products from Lineage Cell Therapeutics – previously BioTime/ESI Bio/Glycosan. HyStem® […]

Siena, Italy and Nottingham, UK – Exosomics SpA, the leading extracellular vesicles biotech company, today announced that it has implemented NanoFCM Co., Ltd’s NanoAnalyzer instrument to offer sophisticated contract research and measurement services worldwide. In this strategic partnership, Exosomics becomes NanoFCM’s approved service supplier of nano-flow cytometry measurements. These can be performed as stand-alone or […]

ReadCoor’s technology simultaneously detects hundreds to thousands of RNA, DNA, proteins, and therapeutics in every cell within intact tissue Spatially surveying thousands of molecules simultaneously drives meaningful insights into disease states and treatment effects Spatial analysis across multiple omic formats gives researchers new insights into cancer, immuno-oncology, gene therapy, and neurodegenerative diseases CAMBRIDGE, Mass., January […]

VANCOUVER, British Columbia  – Aspect Biosystems (“Aspect”) (“the Company”), a biotechnology company pioneering microfluidic 3D bioprinting of human tissues, today announced a US $20 million Series A financing round.  Radical Ventures, a venture capital firm investing in entrepreneurs developing and applying deep tech to solve global problems and transform massive industries, led the round with […]